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Abstract
            Cardiac resynchronisation therapy (CRT) using biventricular (BIV) pacing has proved its 
effectiveness to correct myocardial asynchrony and improve clinical status of patients with 
severe congestive heart failure (CHF) and widened QRS. Despite a different effect on left 
ventricular electrical dispersion, left univentricular (LV) pacing is able to achieve the same 
mechanical synchronisation as BIV pacing in experimental studies and in humans. This results in 
clinical benefits of LV pacing at mid-term follow-up, with significant improvement in functional 
class, quality of life and exercise tolerance at the same extent as those observed with BIV 
stimulation in non randomised studies. Furthermore these benefits are obtained at lesser costs 
and with conventional dual-chamber devices. However, LV pacing has to be compared to BIV 
pacing in randomised trials before being definitely considered as a cost-effective alternative to 
BIV pacing.
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Introduction
              
            Despite advances in drug treatment, congestive heart failure (CHF) remains a major 
health care problem associated with a poor quality of life and a high mortality rate. During the 
past decade, cardiac resynchronisation therapy (CRT) using biventricular (BIV) pacing emerged 
as a promising technique improving quality of life, exercise tolerance and mortality1-3, and is 
now an admitted therapy in a selected population of patients with widened QRS and severe CHF 
despite optimal pharmacological therapy4,5. It has been well documented that intraventricular 
conduction  disturbances,   namely  left   bundle  branch  block,  induce  left   ventricular   (LV) 
activation  delay  leading  to  discoordinated  myocardial  contraction  and,   consecutively,  to 
deleterious   effects   on   myocardial   systolic   function,   diastolic   filling   time   and   mitral 
regurgitation6. Finally this dyssynchronised LV function exaggerates clinical symptoms of CHF. 
The rationale for CRT is based upon the hypothesis that, by correcting inter and intra-ventricular 
asynchrony, BIV pacing improves LV function and favourably affects clinical condition and 
prognosis of patients with severe CHF and prolonged QRS. However it has never been 
demonstrated   that electrical resynchronisation induced by BIV pacing is a sine qua non 
condition to achieve better mechanical coordination as, in experimental data, and despite 
electrical dispersion, LV pacing does as well as BIV pacing on mechanical synchronisation with 
similar hemodynamic benefit7.
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            Many other arguments support the concept that LV univentricular pacing by reversing 
intraventricular dysynchrony is sufficient in humans to improve LV function and clinical status 
at the same extent and at a lower cost-effective ratio than BIV pacing and this is in accordance 
with   the   fact   that   intraventricular   asynchrony   seems   more   relevant   that   interventricular 
asynchrony to predict prognosis in patients with dilated cardiomyopathy8.
Hemodynamic effects of pacing
               The first clinical series with CRT were performed empirically using BIV pacing9. 
However, since this period , several studies in humans have reported similar hemodynamic 
benefit using either LV or BIV pacing during acute studies, showing a decrease in pulmonary 
pressures, an increase in cardiac outpout, systemic blood pressure, and dP/dt when compared to 
baseline or to right ventricular pacing in patients with severe CHF and   intraventricular 
conduction delays10-12. Some authors reported that LV stimulation had even a greater effect on 
LV  dP/dt  than  BIV11,12.  This  hemodynamic  benefit  was  independent  of atrio-ventricular 
conduction as the same effects were observed in patients in sinus rhythm or atrial fibrillation13. 
Furthermore, improvement in myocardial contractility induced by LV pacing was obtained with 
the same extent of reduced energetic cost for the myocardium than with BIV pacing14. Finally, a 
similar reduction in mitral regurgitation was observed by echocardiography using the two pacing 
modes with a significant decrease by 30 to 50 % in mitral jet area or mitral regurgitant orifice 
area in non-randomised studies15-17, despite less striking effects upon LV reverse remodeling 
during LV versus BIV pacing in some studies15-17. 
Clinical benefits
            Whether or not these hemodynamic benefits result in sustained improvement of clinical 
status during permanent LV stimulation has not been extensively investigated until now. 
However, some studies reported significant improvement in both exercise tolerance and quality 
of life at mid-term   follow-up during chronic LV pacing18,19  or failed to demonstrate any 
superiority of BIV  pacing over LV pacing on clinical data17,20. Aurricchio et al compared 3 
months of active LV pacing to 3 months of inactive pacing in 86 patients with severe CHF and 
wide QRS duration. They observed a significant increase in peak V02 (2.46 ml/mn/kg), in 6 
minute walk distance (47 m) and a decrease in quality of life score (8.1) during the active pacing 
period in the group of patients with the longest  QRS duration (above 150 ms)18. In another study 
comparing 2 active periods (4 weeks each) of uniLV and BIV pacing to baseline in a cross-over 
design, the same authors reported similar improvement in functional class, quality of life score, 
and exercise tolerance in the 2 pacing modes20. Our personal studies lead to the same 
conclusions: by comparing to baseline, we found after 12 months of LV pacing in 22 patients 
with severe CHF, sinus rhythm and left bundle branch block a significant improvement in 
NYHA functional class by 40%, exercise tolerance (6 minute walk distance by 30 % and peak 
V02 by 26 %) and norepinephrine level by 37%19. Again and in agreement with the previous 
studies, a similar improvement in functional class and exercise performance was found in 2 
groups of patients (BIV: 12 pts – LV: 14 pts) after 6 months follow-up in a non-randomised 
study, although, as expected, a significant decrease in QRS duration (-19 ms) was showed only 
in the BIV pacing group17.
LV pacing and ventricular asynchrony
            Are these clinical effects correlated with improvement in myocardial synchrony? This is 
an important issue on a physiopathological point of view and for the selection of candidates for 
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LV pacing. In an interesting experimental study using a canine model of cardiac failure and left 
bundle branch block, Leclercq et al examined mechanical and electrical synchrony during right 
atrial, LV and BIV stimulation; as expected, electrical dispersion decreased during BIV pacing 
whereas it increased during LV pacing; however, despite this opposite action upon electrical 
phenomena, the same improvement in mechanical coordination within the LV, measured by 
tagged magnetic resonance imaging, was observed with LV and BIV pacing, and this was 
correlated with improvement in hemodynamics (25 % increase in dP/dt and aortic pulse 
pressure)7. Similarly, in humans, LV dyssynchrony measured either by echocardiographic phase 
analysis, echo-contrast, or tissue Doppler imaging was improved significantly and almost at the 
same extent during LV and BIV pacing16,21,22. The decrease in the septal to lateral contraction 
delay during LV pacing was particularly correlated with an increase in LV ejection fraction or 
dP/dt21,22.
Cost effectiveness
               By comparison to BIV pacing, LV pacing offers several technical and economical 
advantages : 1) if insertion of a third lead (the right ventricular one) is not the most difficult part 
of the operative procedure, it could prolong significantly its duration and the X-ray exposure; 2) 
the presence of 3 leads instead  of 2 induces certainly more adverse events and increases the risk 
of venous thrombosis or mechanical complications; 3) more importantly, uniLV pacing needs 
only a less complex to program and less often subject to dysfunction conventional dual-chamber  
pacemaker. Finally, BIV pacing is more expensive than LV pacing as it implies implantation of a 
supplementary right ventricular lead and of a specific and more costly device: in Europe, the 
extra cost could be approximately evaluated at 30 % and this must be taken in account in the 
context of the growing “epidemic” of heart  failure consecutive to demographic ageing and of the 
control of medical expenses in many countries. 
            So, at this time, there are no arguments in favour of the hypothesis that, for patients with 
severe CHF and enlarged QRS duration, BIV pacing would be significantly more effective than 
LV pacing in terms of mechanical coordination, hemodynamic and clinical benefits. However, 
our knowledge about the effects of LV pacing still suffers some limitations: the present studies 
are only observational and non-randomised. Furthermore, it seems, as shown during acute 
hemodynamic studies, that in some patients LV pacing would not be as effective as BIV pacing 
(but the opposite is true also... ), and this could perhaps be the case in patients with a 
dysfunctional right venricle but no study have focused on this topic at this time. Finally  and 
unlike BIV pacing3,23, no study have examined the effects of LV pacing on mortality and 
morbidity, and whether or not LV pacing improves mortality in severe CHF remains to be 
demonstrated. However, the ongoing trials comparing LV to BIV pacing are not designed to 
show that one of these pacing modalities is better than the other but just equivalent..... an 
argument to think that they are really similar.
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